Alterity Therapeutics ATHE
NASDAQ ATHE
$4.60 +0.15 (+3.37%)
As of: Aug 21, 2026 · 12:10 PM EDT

Alterity Therapeutics (ATHE) Interest Expenses (2014 - 2024)

Alterity Therapeutics (ATHE) posted quarterly Interest Expenses of $1690.2 for Q4 2019, down 99.92% quarter-over-quarter from $2.0 million in Q4 2015.

Alterity Therapeutics (ATHE) Interest Expenses (2014 - 2024) Analysis & Trends

Alterity Therapeutics' Interest Expenses history runs 3 years deep, the most recent figure standing at $1690.2 for Q4 2019.

  • In Q4 2019, Interest Expenses changed N/A year-over-year to $1690.2; the TTM figure through Jun 2021 stood at $1690.2 (changed 0.0% YoY), while the FY2025 annual figure was $3963.0, down 16.68% from the prior year.
  • Interest Expenses for Q4 2019 stood at $1690.2, down from $2.0 million in the prior quarter.
  • The five-year high for Interest Expenses was $2.0 million in Q4 2015, with the low at $1690.2 in Q4 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Vertex Pharmaceuticals 139.77 Bn 131.91 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 86.74 Bn 78.75 Bn 3.93 Bn 11.00 Mn
3 Argenx Se 65.36 Bn 60.17 Bn 1.37 Bn -
4 Moderna 59.60 Bn 54.47 Bn 52.00 Mn -
5 BeOne Medicines 42.10 Bn 37.00 Bn 1.53 Bn 39.74 Mn
6 Alnylam Pharmaceuticals 31.80 Bn 28.49 Bn 992.69 Mn 82.05 Mn
7 BioNTech SE 28.13 Bn 9.73 Bn 668.28 Mn -4.89 Mn
8 Insmed 27.54 Bn 26.38 Bn 358.27 Mn 20.27 Mn
9 Royalty Pharma 27.31 Bn 26.47 Bn - 93.62 Mn
10 Alterity Therapeutics 49.04 Mn 16.74 Mn - 195,281.98

Historic Data

Download Data
DateValue
Jun 30, 2024 -4,756.18
Jun 30, 2024 -4,756.18
Dec 31, 2023 -2,674.27
Dec 31, 2023 -2,674.27
Jun 30, 2023 -3,051.07
Jun 30, 2023 -3,051.07
Jun 30, 2022 -1,636.67
Jun 30, 2022 -1,636.67
Jun 30, 2021 -1,000.30
Jun 30, 2021 -1,000.30
Jun 30, 2020 -2,541.72
Jun 30, 2020 -2,541.72
Dec 31, 2019 1,690.21
Dec 31, 2019 1,690.21
Dec 31, 2015 2.00 Mn
Dec 31, 2015 2.00 Mn
Dec 31, 2014 2.85 Mn
Dec 31, 2014 2.85 Mn